 | feb-2017 | Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry | Dávila-Seijo, Paula; Dauden, Esteban; Descalzo, M. A.; Carretero, Gregorio; Carrascosa, José Manuel; VANACLOCHA, FRANCISCO JOSE; Gómez García, Francisco José; De la Cueva-Dobao, Pablo; Herrera-Ceballos, Enrique; Belinchón, Isabel; López Estebaranz, José Luis; Alsina, Merce; Sánchez-Carazo, José Luis; Ferrán, Marta; Torrado, Rosa |  |
 | abr-2012 | Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: patients ineligible vs eligible for randomized controlled trials | Garcia-Doval, Ignacio; Carretero, Gregorio; VANACLOCHA, FRANCISCO JOSE; Ferrandiz, Carlos; Daudén, Esteban; sanchez-carazo, jose luis; Alsina, Mercé; Herrera-Ceballos, Enrique; Gómez García, Francisco José; Ferrán, Marta; López Estebaranz, José Luis; Hernanz, José Manuel; Belinchón , Isabel ; Vilar-Alejo, Jaime; Rivera, Raquel |  |
.png){kind=logo}